General Information of the Drug (ID: M6ADRUG0179)
Name
BTYNB
Synonyms
BTYNB, 304456-62-0, 2-(((5-Bromothiophen-2-yl)methylene)amino)benzamide, Benzamide, 2-[[(5-bromo-2-thienyl)methylene]amino]-, MDK6620, 2-[(5-bromothiophen-2-yl)methylideneamino]benzamide, 2-{[(E)-(5-bromothiophen-2-yl)methylidene]amino}benzamide, 2-{[(5-bromo-2-thienyl)methylene]amino} benzamide, 2-[(E)-[(5-BROMOTHIOPHEN-2-YL)METHYLIDENE]AMINO]BENZAMIDE, BTYNB IMP1 Inhibitor, TimTec1_002386, SCHEMBL10090730, HMS1540M10, MFCD00977636, s9871, STK014922, AKOS000484586, AKOS040759630, BS-48808, DA-71795, HY-124447, CS-0086494, E85137, 2-((5-Bromothiophen-2-yl)methyleneamino)benzamide, 2-{[(5-Bromothien-2-yl)methylene]amino}benZamide, SR-01000204166, 2-[[(5-bromo-2-thienyl)methylene]amino]-benzamide, SR-01000204166-1, (E)-2-(((5-Bromothiophen-2-yl)methylene)amino)benzamide
    Click to Show/Hide
Structure
3D MOL
Formula
C12H9BrN2OS
InChI
InChI=1S/C12H9BrN2OS/c13-11-6-5-8(17-11)7-15-10-4-2-1-3-9(10)12(14)16/h1-7H,(H2,14,16)
InChIKey
OZEADOPONHLEDS-UHFFFAOYSA-N
PubChem CID
721984
References
Ref 1 ClinicalTrials.gov (NCT03500991) HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors